Human and murine immune responses to a novel Leishmania major recombinant protein encoded by members of a multicopy gene family

Infection and Immunity

Volumn 66, Issue 7, 1998, Pages 3279-3289

  Webb, John R ^a,e,f   Campos Neto, Antonio ^a   Ovendale, Pamela J ^b   Martin, Tricia I ^a   Stromberg, Erika J ^b   Badaro, Roberto ^d   Reed, Steven G ^a,b,c  

^a INFECTIOUS DISEASE RESEARCH INSTITUTE   (United States)

^b GLAXOSMITHKLINE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^e UNIVERSITY OF OTTAWA   (Canada)

^f Medical Research Council of Canada

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; RECOMBINANT PROTEIN;

ANIMAL CELL; ANTIBODY TITER; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LEISHMANIA MAJOR; MOUSE; MULTIGENE FAMILY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMASTIGOTE; PROTEIN ANALYSIS; PROTEIN BINDING; SEQUENCE HOMOLOGY; VACCINATION;

EID: 0031842834     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.66.7.3279-3289.1998     Document Type: Article

References (58)

1. Afonso, L. C., T. M. Scharton, L. Q. Vieira, M. Wysocka, G. Trinchieri, and P. Scott. 1994. The adjuvant effect of interleukin-12 in a vaccine against Leishmania major. Science 263:235-237.
2. Andersen, P. 1994. Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins. Infect. Immun. 62:2536-2544.
3. Bates, P. A., and D. M. Dwyer. 1987. Biosynthesis and secretion of acid phosphatase by Leishmania donovani promastigotes. Mol. Biochem. Parasitol. 26:289-296.
4. Bates, P. A., M. Gottlieb, and D. M. Dwyer. 1988. Leishmania donovani: identification of glycoproteins released by promastigotes during growth in vitro. Exp. Parasitol. 67:199-209.
5. Berman, J. D. 1997. Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years. Clin. Infect. Dis. 24:684-703.
6. Blander, S. J., and M. A. Horwitz. 1991. Vaccination with the major secretory protein of Legionella induces humoral and cell-mediated immune responses and protective immunity across different serogroups of Legionella pneumophila and different species of Legionella. J. Immunol. 147:285-291.
7. Buchmuller-Rouiller, Y., and J. Mauel. 1987. Impairment of the oxidative metabolism of mouse peritoneal macrophages by intracellular Leishmania spp. Infect. Immun. 55:587-593.
8. Campos-Neto, A., L. Soong, J. L. Cordova, D. Sant'Angelo, Y. A. W. Skeiky, N. H. Ruddle, S. G. Reed, Jr., C. Janeway, and D. McMahon-Pratt. 1995. Cloning and expression of a Leishmania donovani gene instructed by a peptide isolated from major histocompatibility complex class II molecules of infected macrophages. J. Exp. Med. 182:1423-1433.
9. Carvalho, E. M., R. Badaro, S. G. Reed, W. D. Johnson, Jr., and T. C. Jones. 1985. Absence of gamma interferon and interleukin-2 production during active visceral leishmaniasis. J. Clin. Invest. 76:2066-2069.
10. Chae, H. Z., S. J. Chung, and S. G. Rhee. 1994. Thioredoxin-dependent peroxide reductase from yeast. J. Biol. Chem. 269:27670-27678.
11. Chae, H. Z., I. H. Kim, K. Kim, and S. G. Rhee. 1993. Cloning, sequencing, and mutation of thiol-specific antioxidant gene of Saccharomyces cerevisiae. J. Biol. Chem. 268:16815-16821.
12. Chae, H. Z., K. Robison, L. B. Poole, G. Church, G. Storz, and S. G. Rhee. 1994. Cloning and sequencing of thiol-specific antioxidant from mammalian brain: alkyl hydroperoxide reductase and thiol-specific antioxidant define a large family of antioxidant enzymes. Proc. Natl. Acad. Sci. USA 91:7017-7021.
13. Chae, H. Z., T. B. Uhm, and S. G. Rhee. 1994. Dimerization of thiol-specific antioxidant and the essential role of cysteine 47. Proc. Natl. Acad. Sci. USA 91:7022-7026.
14. Chakraborty, R., S. Mukherjee, and M. K. Basu. 1996. Oxygen-dependent leishmanicidal activity of stimulated macrophages. Mol. Cell. Biochem. 154: 23-29.
15. Connell, N. D., E. Medina-Acosta, W. R. McMaster, B. R. Bloom, and D. G. Russell. 1993. Effective immunization against cutaneous leishmaniasis with recombinant bacille Calmette-Guerin expressing the Leishmania surface proteinase gp63. Proc. Natl. Acad. Sci. USA 90:11473-11477.
16. Feinberg, A. P., and B. Vogelstein. 1983. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 132:6-13.
17. Ghalib, H. W., M. R. Piuvezam, Y. A. Skeiky, M. Siddig, F. A. Hashim, A. M. el-Hassan, D. M. Russo, and S. G. Reed. 1993. Interleukin 10 production correlates with pathology in human Leishmania donovani infections. J. Clin. Invest. 92:324-329.
18. Goyal, N., U. Roy, and A. K. Rastogi. 1996. Relative resistance of promastigotes of a virulent and an avirulent strain of Leishmania donovani to hydrogen peroxide. Free Radic. Biol. Med. 21:683-689.
19. Handman, E., F. M. Symons, T. M. Baldwin, J. M. Curtis, and J. P. Scheerlinck. 1995. Protective vaccination with promastigote surface antigen 2 from Leishmania major is mediated by a TH1 type of immune response. Infect. Immun. 63:4261-4267.
20. Horwitz, M. A., B. W. Lee, B. J. Dillon, and G. Harth. 1995. Protective immunity against tuberculosis induced by vaccination with major extracellular proteins of Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 92: 1530-1534.
21. Hubbard, R. D., C. M. Flory, and F. M. Collins. 1992. Immunization of mice with mycobacterial culture filtrate proteins. Clin. Exp. Immunol. 87:94-98.
22. Ilg, T., Y. D. Stierhof, D. Craik, R. Simpson, E. Handman, and A. Bacic. 1996. Purification and structural characterization of a filamentous, mucin-like proteophosphoglycan secreted by Leishmania parasites. J. Biol. Chem. 271:21583-21596.
23. Ishii, T., M. Yamada, H. Sato, M. Matsue, S. Taketani, K. Nakayama, Y. Sugita, and S. Bannai. 1993. Cloning and characterization of a 23-kDa stress-induced mouse peritoneal macrophage protein. J. Biol. Chem. 268: 18633-18636.
24. James, S. L., and C. Nacy. 1993. Effector functions of activated macrophages against parasites. Curr. Opin. Immunol. 5:518-523.
25. Jardim, A., D. L. Tolson, S. J. Turco, T. W. Pearson, and R. W. Olafson. 1991. The Leishmania donovani lipophosphoglycan T lymphocyte-reactive component is a tightly associated protein complex. J. Immunol. 147:3538-3544.
26. Klimowski, L., R. Chandrashekar, and C. A. Tripp. 1997. Molecular cloning, expression and enzymatic activity of a thioredoxin peroxidase from Dirofilaria immitis. Mol. Biochem. Parasitol. 90:297-306.
27. + T cells in leishmaniasis. Immunol. Today 10:40-45.
28. Lovelace, J. K., and M. Gottlieb. 1986. Comparison of extracellular acid phosphatases from various isolates of Leishmania. Am. J. Trop. Med. Hyg. 35:1121-1128.
29. McMahon-Pratt, D., D. Rodriguez, J.-R. Rodriguez, Y. Zhang, K. Manson, C. Bergman, L. Rivas, J. F. Rodriguez, K. L. Lohman, N. H. Ruddle, and M. Esteban. 1943. Recombinant vaccinia viruses expressing GP46/M-2 protect against Leishmania infection. Infect. Immun. 61:3351-3359.
30. McSorley, S. J., D. Xu, and F. Y. Liew. 1997. Vaccine efficacy of Salmonella strains expressing glycoprotein 63 with different promoters. Infect. Immun. 65:171-178.
31. Mehlotra, R. K. 1996. Antioxidant defense mechanisms in parasitic protozoa. Crit. Rev. Microbiol. 22:295-314.
32. Mosmann, T. R., and R. L. Coffman. 1989. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:145-173.
33. Mougneau, E., F. Altare, A. E. Wakil, S. Zheng, T. Coppola, Z.-E. Wang, R. Waldmann, R. M. Locksley, and N. Glaichenhaus. 1995. Expression cloning of a protective Leishmania antigen. Science 268:563-566.
34. Muller, I., J. A. Garcia-Sanz, R. Titus, R. Behin, and J. Louis. 1989. Analysis of the cellular parameters of the immune responses contributing to resistance and susceptibility of mice to infection with the intracellular parasite, Leishmania major. Immunol. Rev. 112:95-113.
35. Muller, I., T. Pedrazzini, J. P. Farrell, and J. Louis. 1989. T-cell responses and immunity to experimental infection with Leishmania major. Annu. Rev. Immunol. 7:561-578.
36. Murray, P. J., and T. W. Spithill. 1991. Variants of a Leishmania surface antigen derived from a multigenic family. J. Biol. Chem. 266:24477-24484.
37. Netto, L. E. S., H. Z. Chae, S. W. Kang, S. G. Rhee, and E. R. Stadtman. 1996. Removal of hydrogen peroxide by thiol-specific antioxidant enzyme (TSA) is involved with its antioxidant properties. TSA possesses thiol peroxidase activity. J. Biol. Chem. 271:15315-15321.
38. O'Toole, P. W., S. M. Logan, M. Kostrzynska, T. Wadstrom, and T. J. Trust. 1991. Isolation and biochemical and molecular analyses of a species-specific protein antigen from the gastric pathogen Helicobacter pylori. J. Bacteriol. 173:505-513.
39. Pal, P. G., and M. A. Horwitz. 1992. Immunization with extracellular proteins of Mycobacterium tuberculosis induces cell-mediated immune responses and substantial protective immunity in a guinea pig model of pulmonary tuberculosis. Infect. Immun. 60:4781-4792.
40. Reed, S. L., B. M. Flores, M. A. Batzer, M. A. Stein, V. L. Stroeher, J. E. Carlton, D. L. Diedrich, and B. E. Torian. 1992. Molecular and cellular characterization of the 29-kilodalton peripheral membrane protein of Entamoeba histolytica: differentiation between pathogenic and nonpathogenic isolates. Infect. Immun. 60:542-549.
41. Reiner, S. L., and R. M. Locksley. 1995. The regulation of immunity to Leishmania major. Annu. Rev. Immunol. 13:151-177.
42. Russo, D. M., J. M. Burns, Jr., E. M. Carvalho, R. J. Armitage, K. H. Grabstein, L. L. Button, W. R. McMaster, and S. G. Reed. 1991. Human T cell responses to gp63, a surface antigen of Leishmania. J. Immunol. 147: 3575-3580.
43. Russo, D. M., S. J. Turco, J. M. Burns, Jr., and S. G. Reed. 1992. Stimulation of human T lymphocytes by Leishmania lipophosphoglycan-associated proteins. J. Immunol. 148:202-207.
44. Sacks, D. L., S. Lata Lal, S. N. Shvivastava, J. Blackwell, and F. A. Neva. 1987. An analysis of T cell responsiveness in Indian kala-azar. J. Immunol. 138:908-913.
45. Scott, P. 1991. IFN-gamma modulates the early development of Th1 and Th2 responses in a murine model of cutaneous leishmaniasis. J. Immunol. 147: 3149-3155.
46. Scott, P., P. Caspar, and A. Sher. 1990. Protection against Leishmania major in BALB/c mice by adoptive transfer of a T cell clone recognizing a low molecular weight antigen released by promastigotes. J. Immunol. 144:1075-1079.
47. Seder, R. Personal communication.
48. Skeiky, Y. A. W., D. R. Benson, J. A. Guderian, J. A. Whittle, O. Bacelar, E. M. Carvalho, and S. G. Reed. 1995. Immune responses of leishmaniasis patients to heat shock proteins of Leishmania species and humans. Infect. Immun. 63:4105-4114.
49. Skeiky, Y. A. W., J. A. Guderian, D. R. Benson, O. Bacelar, E. M. Carvalho, M. Kubin, R. Badaro, G. Trinchieri, and S. G. Reed. 1995. A recombinant Leishmania antigen that stimulates human peripheral blood mononuclear cells to express a Th1-type cytokine profile and to produce interleukin 12. J. Exp. Med. 181:1527-1537.
50. Soong, C. J., B. E. Torian, M. D. Abd-Alla, T. F. Jackson, V. Gatharim, and J. I. Ravdin. 1995. Protection of gerbils from amebic liver abscess by immunization with recombinant Entamoeba histolytica 29-kilodalton antigen. Infect. Immun. 63:472-477.
51. Symons, F. M., P. J. Murray, H. Ji, R. J. Simpson, A. H. Osborn, R. Cappai, and E. Handman. 1994. Characterization of a polymorphic family of integral membrane proteins in promastigotes of different Leishmania species. Mol. Biochem. Parasitol. 67:103-113.
52. Torian, B. E., B. M. Flores, V. L. Stroeher, F. S. Hagen, and W. E. Stamm. 1990. cDNA sequence analysis of a 29-kDa cysteine-rich surface antigen of pathogenic Entamoeba histolytica. Proc. Natl. Acad. Sci. USA 87:6358-6362.
53. Webb, J. R., D. Kaufmann, A. Campos-Neto, and S. G. Reed. 1996. Molecular cloning of a novel protein antigen of Leishmania major that elicits a potent immune response in experimental murine leishmaniasis. J. Immunol. 157:5034-5041.
54. Wiese, M., T. Ilg, F. Lottspeich, and P. Overath. 1995. Ser/Thr-rich repetitive motifs as targets for phosphoglycan modifications in Leishmania mexicana secreted acid phosphatase. EMBO J. 14:1067-1074.
55. Wilson, K., S. Hanson, S. Landfear, and B. Ullman 1991. Nucleotide sequence of the Leishmania donovani medRNA gene. Nucleic Acids Res. 19:5787.
56. Wilson, M. E., B. M. Young, K. P. Anderson, J. V. Weinstock, A. Metwali, K. M. Ali, and J. E. Donelson. 1995. A recombinant Leishmania chagasi antigen that stimulates cellular immune responses in infected mice. Infect. Immun. 63:2062-2069.
57. Xu, D., S. J. McSorley, S. N. Chatfield, G. Dougan, and F. Y. Liew. 1995. Protection against Leishmania major infection in genetically susceptible BALB/c mice by gp63 delivered orally in attenuated Salmonella typhimurium (AroA-AroD-). Immunology 85:1-7.
58. Zarley, J. H., B. E. Britigan, and M. E. Wilson. 1991. Hydrogen peroxide-mediated toxicity for Leishmania donovani chagasi promastigotes. Role of hydroxyl radical and protection by heat shock. J. Clin. Invest. 88:1511-1521.